Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Americas Gastrointestinal Drugs Market

ID: MRFR/Pharma/0140-HCR
50 Pages
Rahul Gotadki
Last Updated: April 06, 2026
Americas Gastrointestinal Drugs Market Research Report, by Drug Category (Acid Neutralizers, Laxatives and Antidiarrheal, Anti-inflammatory drugs, and Others), By Route of Administration (Oral, Parenteral, Rectal), By disease type (Gastroesophageal Reflux Disease, Inflammatory Bowel Disease and Other), By end user (Hospital Pharmacies, Retail Pharmacies and Other) - Forecast till 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 INTRODUCTION
    1. 1.1 DEFINITION
      1. 1.2.1 RESEARCH OBJECTIVE
      2. 1.2.2 ASSUMPTIONS & LIMITATIONS
        1. 1.2.2.1 ASSUMPTIONS
    2. SCOPE OF STUDY
    3. LIMITATIONS
    4. 1.3 MARKET STRUCTURE:
  2. 2 RESEARCH METHODOLOGY
    1. RESEARCH PROCESS:
    2. 2.2 PRIMARY RESEARCH
    3. 2.3 SECONDARY RESEARCH:
  3. MARKET DYNAMICS
    1. 3.1 DRIVERS
    2. 3.2 RESTRAINTS
    3. 3.3 OPPORTUNITIES
    4. 3.4 MACROECONOMIC
    5. INDICATORS
  4. 4 MARKET FACTOR ANALYSIS
    1. 4.1 PORTERS FIVE FORCES MODEL
    2. 4.2 BARGAINING POWER OF SUPPLIERS
    3. BARGAINING POWER OF BUYERS
    4. 4.4 THREAT
    5. OF NEW ENTRANTS
    6. 4.5 THREAT OF SUBSTITUTES
    7. 4.6 INTENSITY OF RIVALRY
  5. Americas Gastrointestinal Drugs Market, BY DRUG CATEGORY
    1. ACID NEUTRALIZERS
    2. H2 ANATAGONISTS
    3. OTHERS
    4. ANTINFLAMMATORY
    5. OTHER
  6. 5.1.1 ANTACID
  7. 5.1.3 PROTON PUMP INHIBITORS
    1. 5.2 LAXATIVES & ANTIDIARRHEAL
    2. 5.4 ANTIEMETIC
  8. 6 Americas Gastrointestinal Drugs Market, BY
    1. ROUTE OF ADMINISTRATION
    2. 6.1 ORAL
    3. 6.2 PARENTAL
    4. 6.3 RECTAL
  9. 7 AMERICAS GASTROINTESTINAL
  10. Americas Gastrointestinal Drugs Market, BY DISEASES TYPE
    1. 7.1 GASTROESPHAGEAL REFLUX
    2. DISEASES
    3. 7.2 INFLAMMATORY BOWEL DISEASES
      1. 7.2.2 ULCERTAVIE COLITIS
        1. 7.2.2.1 ULCERATIVE PROCTITIS
        2. 7.2.2.2 PROCTOSIGMOIDITIS
        3. 7.2.2.3 LEFT SIDED COLITIS
        4. 7.2.2.4 PANCOLITIS
        5. 7.2.2.5 ACUTE SEVERE ULCERTATIVE COLITIS
    4. CHRON’S DISEASE
    5. OTHER.
  11. 8 Americas Gastrointestinal Drugs Market, BY
    1. END USERS
    2. 8.1 HOSPITAL PHARMACIES
    3. 8.2 RETAIL
    4. PHARMACIES
    5. 8.3 OTHERS
  12. 9 AMERICAS
  13. Americas Gastrointestinal Drugs Market, BY REGION
    1. 9.1 INTRODUCTION
      1. 9.1.2 NORTH AMERICA
    2. 91.3 SOUTH AMERICA
  14. 10 COMPETITIVE LANDSCAPE
    1. MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS
    2. STRATEGIC PARTNERSHIP
    3. & ACQUISITION
  15. 10.1.2 MERGER
  16. 11 COMPANY PROFILE
    1. 11.1 ABBVIE INC.
      1. 11.1.1 OVERVIEW
      2. 11.1.2 PRODUCT OVERVIEW
      3. 11.1.4 KEY DEVELOPMENTS
    2. FINANCIALS
    3. 11.2 ABBOTT LABORATORIES
      1. 11.2.1 OVERVIEW
      2. 11.2.2 PRODUCT OVERVIEW
      3. 11.2.4 KEY DEVELOPMENTS
    4. FINANCIALS
    5. 11.3 ALLERGEN PLC.
      1. 11.3.1 OVERVIEW
      2. 11.3.2 PRODUCT OVERVIEW
      3. 11.3.4 STRATEGY
    6. FINANCIALS
    7. KEY DEVELOPMENT
    8. 11.4 BAYER AG
      1. 11.4.1 OVERVIEW
      2. 11.4.2 PRODUCT OVERVIEW
      3. 11.4.3 FINANCIALS
      4. 11.4.4 KEY DEVELOPMENTS
    9. 11.5 BOEHRINGER INGELHEIM GMBH
      1. 11.5.2 PRODUCT OVERVIEW
      2. 11.5.3 FINANCIALS
    10. OVERVIEW
    11. KEY DEVELOPMENTS
    12. 11.6 GALXOSMITHKLINE
      1. 11.6.1 OVERVIEW
      2. 11.6.2 PRODUCT OVERVIEW
      3. 11.6.3 FINANCIALS
    13. KEY DEVELOPMENTS
    14. 11.7 JASSEN PHARMACEUTICALS INC
      1. 11.7.1 OVERVIEW
      2. 11.7.2 PRODUCT OVERVIEW
      3. 11.7.3 FINANCIALS
    15. KEY DEVELOPMENTS
  17. 11 8 OTHERS

Americas Gastrointestinal Drugs Market Segmentation

Market Segmentation Overview

  • Detailed segmentation data will be available in the full report
  • Comprehensive analysis by multiple parameters
  • Regional and country-level breakdowns
  • Market size forecasts by segment